Halpern iteration of Cesàro means for asymptotically nonexpansive mappings

ABSTRACT: Using a new proof technique which is independent of the approximation fixed point of T (limn→∞ xn − T xn = 0) and the convergence of the Browder type iteration path (zt = tu + (1 − t)T zt), the strong convergence of the Halpern iteration {xn} of Cesàro means for asymptotically nonexpansive self-mappings T , defined by xn+1 = αnu + (1 − αn)(n + 1) −1 n j=0 T j xn for n 0, is proved in a uniformly convex Banach space E with a uniformly Gâteaux differentiable norm whenever {αn} is a real sequence in (0, 1) satisfying the conditions limn→∞ bn/αn = 0 and limn→∞ αn = 0 and ∞ n=0 αn = ∞

Safety Risk Analysis of Unmanned Ships in Inland Rivers Based on a Fuzzy Bayesian Network

Risk factor identification is the basis for risk assessment. To quantify the safety risks of unmanned vessels in inland rivers, through analysis of previous studies, the safety risk impact factor framework of unmanned vessels in inland rivers is established based on three aspects: the ship aspect, the environmental aspect, and the management and control aspect. Relying on Yangtze River, a fuzzy Bayesian network of the sailing safety risk of unmanned ships in inland rivers is constructed. The proposed safety risk model has considered different operational and environmental factors that affect shipping operations. Based on the fuzzy set theory, historical data, and expert judgments and on previous works are used to estimate the base value (prior values) of various risk factors. The case study assessed the safety risk probabilities of unmanned vessels in Yangtze River. By running uncertainty and sensitivity analyses of the model, a significant change in the likelihood of the occurrence of safety risk is identified, and suggests a dominant factor in risk causation. The research results can provide effective information for analyzing the current safety status for navigation systems of unmanned ships in inland rivers. The estimated safety risk provides early warning to take appropriate preventive and mitigative measures to enhance the overall safety of shipping operations. Document type: Articl

Moxibustion for Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background. The complementary and alternative medicines in treatment of diarrhea-predominant irritable bowel syndrome (IBS-D) are controversial. Methods. We searched PubMed, Ovid Embase, Web of Science, Cochrane Library databases, CNKI, Wanfang Database, CBM, VIP, and AMED for randomized controlled trials (RCTs) of moxibustion compared with pharmacological medications in patients with IBS-D. A meta-analysis was performed using both fixed and random-effects models based on heterogeneity across studies. Results. In total, 568 patients in 7 randomized controlled trials were randomly treated with moxibustion and pharmacological medications. The improvement of global IBS-D symptoms and overall scores was significant (P=0.0001 and P<0.0001, resp.) in patients treated by moxibustion only compared to pharmacological medications. The specific IBS-D symptoms of abdominal pain, abdominal distension, abnormal stool, and defecation frequency were alleviated in patients treated by moxibustion compared to pharmacological medications, but no significance was found except for abdominal distension and defecation frequency (P=0.03 and P=0.02, resp.). There were no serious adverse events related to moxibustion. Conclusions. Moxibustion appears to be effective in treating IBS-D compared with pharmacological medications. However, further large, rigorously designed trials are warranted due to insufficient methodological rigor in the included trials

Moxibustion for Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background. The complementary and alternative medicines in treatment of diarrhea-predominant irritable bowel syndrome (IBS-D) are controversial. Methods. We searched PubMed, Ovid Embase, Web of Science, Cochrane Library databases, CNKI, Wanfang Database, CBM, VIP, and AMED for randomized controlled trials (RCTs) of moxibustion compared with pharmacological medications in patients with IBS-D. A meta-analysis was performed using both fixed and random-effects models based on heterogeneity across studies. Results. In total, 568 patients in 7 randomized controlled trials were randomly treated with moxibustion and pharmacological medications. The improvement of global IBS-D symptoms and overall scores was significant ( = 0.0001 and &lt; 0.0001, resp.) in patients treated by moxibustion only compared to pharmacological medications. The specific IBS-D symptoms of abdominal pain, abdominal distension, abnormal stool, and defecation frequency were alleviated in patients treated by moxibustion compared to pharmacological medications, but no significance was found except for abdominal distension and defecation frequency ( = 0.03 and = 0.02, resp.). There were no serious adverse events related to moxibustion. Conclusions. Moxibustion appears to be effective in treating IBS-D compared with pharmacological medications. However, further large, rigorously designed trials are warranted due to insufficient methodological rigor in the included trials

Epidemiology and clinical course of COVID-19 in Shanghai, China.

Background: Novel coronavirus pneumonia (COVID-19) is prevalent around the world. We aimed to describe epidemiological features and clinical course in Shanghai. Methods: We retrospectively analysed 325 cases admitted at Shanghai Public Health Clinical Center, between January 20 and February 29, 2020. Results: 47.4% (154/325) had visited Wuhan within 2 weeks of illness onset. 57.2% occurred in 67 clusters; 40% were situated within 53 family clusters. 83.7% developed fever during the disease course. Median times from onset to first medical care, hospitalization and negative detection of nucleic acid by nasopharyngeal swab were 1, 4 and 8 days. Patients with mild disease using glucocorticoid tended to have longer viral shedding in blood and feces. At admission, 69.8% presented with lymphopenia and 38.8% had elevated D-dimers. Pneumonia was identified in 97.5% (314/322) of cases by chest CT scan. Severe-critical patients were 8% with a median time from onset to critical disease of 10.5 days. Half required oxygen therapy and 7.1% high-flow nasal oxygen. The case fatality rate was 0.92% with median time from onset to death of 16 days. Conclusion: COVID-19 cases in Shanghai were imported. Rapid identification, and effective control measures helped to contain the outbreak and prevent community transmission